CLN · "CELON PHARMA" SPÓŁKA AKCYJNA
Market Cap
1.07B PLN
Shares
53.91M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close18.8400 PLN
Open19.0800 PLN
Day18.5800–19.2200 PLN
52W close18.7000–23.5000 PLN
Avg vol 30d16K
Last earningsApr 22, 2026
DataJan 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 18.7000 PLN
Now 18.8400 PLN · 3%
Range high 23.5000 PLN
vs 200-day avg -10%
vs 50-day avg -10%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XWAR:CLN | -3.4% | -12.8% | -9.9% | +0.8% | -7.4% |
Exchange listing
- Market
- XWAR
- Ticker
- CLN
- ISIN
- PLCLNPH00015
- Security
- —
- Trading currency
- PLN
Company
- Website
- https://www.celonpharma.com/
- Investor relations
- https://celonpharma.com/inwestorzymedia/
Other listings of this company
No other verified listings are available.
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2024-06-27 | 0.0800 PLN |
| 2023-06-29 | 0.0900 PLN |
| 2021-07-14 | 0.0700 PLN |
| 2020-06-01 | 0.0800 PLN |
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 00:00 UTC | rozszerzony skonsolidowany raport za III kwartał 2026 roku – 18 listopada 2026 r. | Event |
Earnings calls
-
Earnings call · Q1 2026 2026-04-22raport roczny za 2025 rok oraz skonsolidowany raport roczny za 2025 rok – 22 kwietnia 2026 r